Search research articles
Contact Us
Filters
Showing results (21-30 of 110) with videos related to
Page
of 11
Sort By:
Histopathology
|
December 18, 2019
Ovarian germ cell tumour classification: views from the testis
Daniel M Berney, Sara Stoneham, Rupali Arora, et al.
British Journal of Haematology
|
August 12, 2009
Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy
Tamara Intermesoli, Jonathan Shamash, Ama Rohatiner, et al.
Urologic Oncology
|
September 6, 2011
A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder
Madhumita Bhattacharyya, Tom Powles, Katherine Mutsvangwa, et al.
Urologia Internationalis
|
July 14, 2007
A comparison of the platinum analogues in bladder cancer cell lines
Thomas Powles, Jacky Perry, Jonathan Shamash, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 8, 2010
The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers
Norbert Avril, Fatima Dambha, Iain Murray, et al.
Human Pathology
|
November 1, 2019
Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition
Glenda Scandura, Thomas Wagner, Luis Beltran, et al.
Oncogene
|
December 3, 2003
Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity
Wai Man Liu, Thomas Powles, Jonathan Shamash, et al.
Leukemia & Lymphoma
|
July 9, 2008
Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach
Wai M Liu, Katherine A Scott, Jonathan Shamash, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 21, 2023
Corrigendum to "Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?": [Modern Pathology 34 (2021) 834-841]
Glenda Scandura, Thomas Wagner, Luis Beltran, et al.
Melanoma Research
|
April 12, 2003
Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial
Maria L Nystrom, Jeremy P Steele, Jonathan Shamash, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 110) with videos related to
Sort By:
Page
of 11
Histopathology
|
December 18, 2019
Ovarian germ cell tumour classification: views from the testis
Daniel M Berney, Sara Stoneham, Rupali Arora, et al.
British Journal of Haematology
|
August 12, 2009
Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy
Tamara Intermesoli, Jonathan Shamash, Ama Rohatiner, et al.
Urologic Oncology
|
September 6, 2011
A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder
Madhumita Bhattacharyya, Tom Powles, Katherine Mutsvangwa, et al.
Urologia Internationalis
|
July 14, 2007
A comparison of the platinum analogues in bladder cancer cell lines
Thomas Powles, Jacky Perry, Jonathan Shamash, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 8, 2010
The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers
Norbert Avril, Fatima Dambha, Iain Murray, et al.
Human Pathology
|
November 1, 2019
Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition
Glenda Scandura, Thomas Wagner, Luis Beltran, et al.
Oncogene
|
December 3, 2003
Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity
Wai Man Liu, Thomas Powles, Jonathan Shamash, et al.
Leukemia & Lymphoma
|
July 9, 2008
Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach
Wai M Liu, Katherine A Scott, Jonathan Shamash, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 21, 2023
Corrigendum to "Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?": [Modern Pathology 34 (2021) 834-841]
Glenda Scandura, Thomas Wagner, Luis Beltran, et al.
Melanoma Research
|
April 12, 2003
Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial
Maria L Nystrom, Jeremy P Steele, Jonathan Shamash, et al.
Page
of 11